0000904454-22-000611.txt : 20221213
0000904454-22-000611.hdr.sgml : 20221213
20221213153449
ACCESSION NUMBER: 0000904454-22-000611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221209
FILED AS OF DATE: 20221213
DATE AS OF CHANGE: 20221213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kapusta Matthew C
CENTRAL INDEX KEY: 0001536290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36294
FILM NUMBER: 221459563
MAIL ADDRESS:
STREET 1: 7358 MCVAY ROAD
CITY: GERMANTOWN
STATE: TN
ZIP: 38138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: uniQure N.V.
CENTRAL INDEX KEY: 0001590560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
BUSINESS PHONE: 1-339-970-7000
MAIL ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
FORMER COMPANY:
FORMER CONFORMED NAME: uniQure B.V.
DATE OF NAME CHANGE: 20131030
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2022-12-09
0
0001590560
uniQure N.V.
QURE
0001536290
Kapusta Matthew C
C/O UNIQURE, N.V.
AMSTERDAM P7
11058BP
1
1
0
0
CEO, Managing Director
Ordinary Shares
2022-12-09
4
S
0
6648
22.44
D
368481
D
As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of performance-based restricted share units.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.39 to $22.60. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Christian Klemt, Attorney-in-Fact
2022-12-13